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1013-7025/Copyrightª 2014, Hong Kong PhAbstract The aims of this study were to determine the 6-minute walk distance (6MWD),
establish prediction equations for the 6MWD in apparently healthy Nigerians, evaluate any ef-
fects regarding participant sex, and compare measured 6MWDs with the predicted 6MWD from
reference equations derived from other populations. Four hundred and twenty two (422)
apparently healthy Nigerians participated in the study. The 6-minute walk test was carried
out according to the American Thoracic Standard-standardized protocol. The 6MWD obtained
from the study was compared with reference values from other foreign populations. There
were no significant differences between the mean age and mean weight of the male and fe-
male participants. However, significant difference existed in the mean height and mean body
mass index (BMI; p < 0.001) of these participants. Male participants covered a statistically sig-
nificant longer distance than female participants (p < 0.001). The mean 6MWD measured in
Nigerian participants (517.6  72.2 m) was statistically lower than 6MWD in Americans, Brazi-
lians, and Tunisians and was higher than in Arabians (p  0.002), respectively. The 6-MWD in
healthy Nigerians cannot be predicted by established reference equations from other popula-
tions. The regression equations established in this study may better predict the distance for
Nigerians.
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The use of field-walk tests in patients with cardiorespiratory
diseases results from the adaptation of the 12-minute run
fitness test developed by Cooper [1]. This test was devel-
oped with the objective of verifying the level of physical
fitness of the United States of America Armed Forces
personnel. The test involved running the longest possible
distance in 12 minutes. In the 1970s, McGavin et al [2]
adapted Cooper’s run fitness test into a 12-minute walk
test (12MWT) with the objective of evaluating the exercise
tolerance of patients with chronic bronchitis. In most pa-
tients with chronic illnesses, the 12MWT was adapted to
shorter distances (e.g., 2, 4, and 6 minutes), mainly because
it was strenuous for patients [3]. By contrast, the 2- or 4-
minute tests presented limited responsiveness, especially
in less debilitated patients [3]. In this sense, the 6-minute
walk test (6MWT) became the most popular among the
tests with controlled duration, and it consists of walking as
fast as possible for 6 minutes. The 6MWTwas first introduced
as a functional exercise test by Lipkin et al [4]. The 6MWT is
a useful assessment instrument for exercise capacity and it
has been shown to provide a clinically useful index of
functional capacity in chronic heart failure (CHF) [5] and
other chronic illnesses. Its results highly correlate with
those of the 12MWT from which it was derived and with
those of cycle ergometer- or treadmill-based exercise tests
[3,6,7]. Because exercise is a physiological form of stress,
dynamic exercise testing has become a valuable noninvasive
method for diagnosis and evaluation of heart diseases in
children and adults [8]. In clinical practice, an objective
estimate of performance and fitness can be obtained
through standardized exercise tests [9]. Such tests provide
objective and reliable estimate of physical working capacity
and maximum oxygen uptake and provide clues to the
mechanism that limit physical working capacity [9].
The 6MWT was originally developed to evaluate the
functional capacity, monitor the effectiveness of several
treatments, and establish the prognosis of patients with
cardiorespiratory diseases [10]. Patients with such dys-
functions presented with exercise intolerance due to mal-
functioning respiratory and/or cardiovascular systems and
peripheral and respiratory skeletal muscle dysfunction [3].
However, more recently, the test has been used to assess
functional exercise capacity in several disease conditions
such as CHF, chronic cardiopulmonary conditions, and
stroke [11e13] even in sub-Saharan African populations. In
patients with cardiorespiratory diseases, oxygen consump-
tion during the 6MWT does not significantly differ from the
maximum oxygen consumption (VO2max) obtained during
incremental laboratory tests performed using cycle
ergometer [14]. Therefore, it is possible to adequately es-
timate the VO2max by the distance walked using the 6-MWT
or 6-minute walk distance (6MWD). Thus, the 6MWT is a
simple and less expensive tool to assess the cardiorespira-
tory fitness [10]. The 6MWT is well-tolerated by patients
and is more representative of the activities of daily living in
comparison with other walk tests [15]. It is frequently used
as an outcome measure in cardiopulmonary and cardio-
vascular rehabilitation and as an assessment tool in the
selection of patients for lung and heart surgery [16,17]. The6MWT is a popular and widely accepted modality of
objective evaluation of functional exercise capacity as it is
inexpensive and simple to perform [18].
Several demographic, anthropometric, and physiological
factors can influence the 6MWD in healthy individuals and in
patients with chronic diseases. Shorter individuals and
women present a shorter step length and, consequently, a
shorter 6MWD [19]. Elderly and obese individuals commonly
have reduced lean body mass and, consequently, a shorter
6MWD. The 6MWT has been found to be influenced by
external complicating factors, such as effort spent and
motivation [20]. Thus, the instructions and the encour-
agement given to the participants must be carefully stan-
dardized and the demographic, anthropometric, and
nutritional differences observed among the different eth-
nicities evaluated must be considered [10]. Greater height
and higher amount of lean mass observed in whites have a
significant impact on the 6MWD [21]. Therefore, the
American Thoracic Society (ATS) encourages the scientific
community to use the standardisation of the 6MWT sug-
gested in its consensus and to develop reference values of
the 6MWD for several ethnicities.
Despite the popularity of the 6MWT in the clinical
setting, there is a paucity of 6MWD reference values ob-
tained from healthy participants [10,22]. This limits the
interpretation of 6MWD in patients and poses problems for
clinicians wishing to provide patients with a measure of
their expected 6MWD in the absence of disease [23]. Recent
studies have established regression equations to predict the
6MWD in healthy Asians [22,24], Americans [25], Brazilians
[26], North Africans [27], and Arabians [28]. However,
regression equations have not been established for the
Nigerian population. This study was therefore aimed at
determining the 6MWD in a healthy sample of Nigerians
aged between 21 and 67 years, identify factors contributing
to distance covered in 6 minutes (6MWD), establish
regression equations for a Nigerian population, and to
compare measured 6MWD with predicted 6MWD from
existing reference equations derived from American, Asian,
North African, and Arabian participants.
Materials and methods
Participants
A total of 422 apparently healthy Nigerian participants (224
males, 198 females) with no history of cardiovascular,
pulmonary, or musculoskeletal disorders participated in the
study. Those who were involved in sports and vigorous ex-
ercises were excluded from participating in the study. The
participants were volunteers from staff and relatives of
patients in Lagos University Teaching Hospital (LUTH),
Lagos, Nigeria.
A ‘rule of thumb’ was adapted to calculate the sample
size for this study [29,30].
(N > 104 þ m) [30]
The sample size to number of predictor ratio was
calculated from the following formula:
67Sample size to number of predictor ratio Z N/m
where N is the sample size, m is the number of independent
variables, which was four in this study (age, height, weight,
and body mass index)
Sample size to number of predictor ratio Z 422/
4 Z 105.5 Z 106
Ethical considerations
The research protocol was approved by the Ethical and
Protocol Review Committee of the LUTH. Informed consent
was obtained from the participants before they were
enrolled in the study.
Procedure
The test procedures were explained to the participants
before the commencement of exercise testing. The ATS-
standardized 6MWT protocol was used.
Protocol
The 6MWTwas carried out using a 30-m straight walk course
marked out on the flat surface of the medical gymnasium,
with chair placed at both ends of the course. Participants
were instructed to stand at the zero mark of the walk
course, and then walk at his/her own pace, to cover as
much ground as possible in a period of 6 minutes. Timing
with a stopwatch began when the participant was instruc-
ted to “go” and ended when the stopwatch read 6 minutes.
Every minute, participant was encouraged with standard-
ized statements “You are doing well” or “Keep up the good
work.” They were allowed to stop and rest during the test
when tired, but were instructed to resume walking as soon
as they were able to do so. The total walking distance
covered during this period was measured and recorded in
metres. The 6MWT was conducted only once on all the
participants to eliminate any learning effect. Immediately
after the test, participants were told to remain in standing
position and the cardiovascular parameters were measured
again and recorded as post-test measurements. Height and
weight were measured using Seca weighteheight scale; the
age, in years, was recorded as at the last birthday. The
distance walked during the test was recorded to the near-
est meters as 6MWD.
Assessment of cardiorespiratory functions
Resting arterial blood pressure (systolic and diastolic in
mmHg) was measured with Omron automatic blood pres-
sure monitor (model HEM-712 CLCN2; Bannockburn, IL,
USA). This instrument was validated using the Accoson
Mercury sphygmomanometer. Regular checks for consis-
tency were routinely done every week. Participants were
required to be seated for at least 20 minutes before mea-
surements were taken following standardized methods
recommended by the American Heart Association [8]. The
average of two systolic and two diastolic measurements
was recorded, respectively. Resting heart rate (beats per
minute or bpm) was measured using an Omron automatic
blood pressure monitor while a polar heart rate monitorwas used to monitor the heart rate during the exercise. The
unit of measurement was bpm. Resting respiratory rate
(cycles per minute) was determined by observing the chest
excursions.
Data analysis
Independent t tests were used to compare characteristics
(age, height weight, and BMI) and 6MWD between male and
female participants. The relationships between 6MWD and
participant characteristics were examined using Pearson’s
correlation coefficients (r). Stepwise regression analysis
was performed on the following variables: age, height,
weight, and BMI to determine their contribution to distance
covered in 6 minutes and to determine tolerance to detect
multicollinearity. The 6MWD measured in this study was
compared with predicted 6MWD derived from other foreign
studies [25e28]. All data were analyzed using SPSS package
(version 17.0; SPSS Inc., Chicago, IL, USA). Data were re-
ported as mean  standard deviation. The level of signifi-
cance was set at p < 0.05.
Results
A summary of the physical characteristics of the partici-
pants is shown in Table 1. The mean height was higher in
males than in females, whereas mean BMI was higher in
females than in males (p < 0.001), respectively. There were
no significant differences in age and weight between male
and female participants.
The 6MWD correlated negatively with the age
(r Z 0.375, p < 0.001), weight (r Z 0.108, p < 0.026),
and BMI (r Z 0.356, p < 0.001), while it correlated
positively with height (rZ þ0.470, p < 0.001) in the overall
analysis of the participants. In male participants, 6MWD
correlated negatively with age (rZ 0.410, p < 0.001) and
positively correlated with height (rZ 0.250). There was no
significant correlation between 6MWD and weight
(rZ 0.018, pZ 0.789) and BMI (rZ 100, pZ 0.170) in
the male participants. In female participants, 6MWD
negatively correlated with age (r Z 0.419, p < 0.001),
weight (r Z 0.267, p < 0.001), and BMI (r Z 0.391,
p < 0.001), whereas it positively correlated with height
(r Z 0.298, p < 0.001). Results are shown in Table 2. The
strongest correlate of 6MWD in the overall analysis was
height with correlation coefficient of þ0.470 followed by
age with correlation coefficient of 0.375 and BMI
(r Z 0.356). The least important correlate of 6MWD was
weight (r Z 0.108) as shown in Table 2.
Table 3 shows stepwise regression analysis of the pre-
dictors of 6MWD in combined participants. Three models
are represented in the table; the model with the highest
regression coefficient (0.550), highest R2 (0.303), and least
standard error of estimate (SEE Z 58.1) was considered
appropriate to predict 6MWD in the overall analysis and
presented as Eq. (1). The prediction equation [Eq. (1)]
showed that age, height, and weight were the determinants
of 6MWD. Height had the most significant contribution to
6MWD with a standardized regression coefficient of 0.479
followed by weight with standardized coefficient of 0.210
and age with standardized coefficient of 0.118
Table 1 Physical characteristics of participants.
Characteristics Combined participants
(n Z 422), mean  SD
Male participants
(n Z 224), mean  SD
Female participants
(n Z 198), mean  SD
t value p
Age (y) 36.4  12.7 35.9  12.4 36.7  13.1 0.702 0.483
Height (m) 1.67  0.08 1.72  0.07 1.62  0.06 15.602 <0.001*
Weight (kg) 70.7  13.7 70.8  12.0 70.6  15.4 0.138 0.891
BMI (kg/m2) 25.3  4.8 20.7  6.9 26.9  5.6 9.149 <0.001*
*Significant at < 0.001.
BMI Z body mass index; SD Z standard deviation.
Table 2 Correlation of 6MWD with age, height, weight, and BMI in combined, male, and female participants.
Variables Combined
participants
(n Z 422),
mean  SD
Correlation
coefficient
(r)
p Male
participants
(n Z 224),
mean  SD
Correlation
coefficient
(r)
p Female
participants
(n Z 198),
mean  SD
Correlation
coefficient
(r)
p
6MWD (m) 517.6  72.2 d d 548.9  67.9 d d 482.5  59.9 d d
Age (y) 36.4  12.7 0.375 <0.001* 35.9  12.4 0.410 <0.001* 36.7  13.1 0.419 <0.001*
Height (m) 1.67  0.08 þ0.470 <0.001* 1.72  0.07 þ0.250 <0.001* 1.62  0.06 þ0.298 <0.001*
Weight (kg) 70.7  13.7 0.108 0.026** 70.8  12.0 0.018 0.789 70.6  15.4 0.267 <0.001*
BMI (kg/m2) 25.3  4.8 0.356 <0.001* 20.9  6.9 0.100 0.170 26.9  5.6 0.391 <0.001*
High and significant negative correlations were seen between 6MWD and age and significant positive correlations between 6MWD and
height in both sexes. However, significant correlations were seen between 6MWD and BMI and weight in female participants only.
*p < 0.001.
**p < 0.05.
6MWD Z 6-minute walk distance; BMI Z body mass index; SD Z standard deviation.
68 O.A. Ajiboye et al.(p Z 0.001) as shown in Table 3. Collinearity/tolerance of
excluding BMI from the equation was 0.430 (p Z 0.794).
Body mass index did not have a significant contribution to
6MWD in the overall data analysis. Model 3 with these
features was considered as the most appropriate equation
for the study.
Table 4 shows stepwise regression analysis of the pre-
dictors of 6MWD in male participants. Two models were
represented in the table; the model with the higher
regression coefficient (0.367), higher R2 (0.135), and least
SEE (61.7) was considered appropriate to predict 6MWD in
the male participants and represented as Eq. (2). The
prediction equation [Eq. (2)] showed that age and heightTable 3 Stepwise regression analysis of the predictors of 6MWD
Model Unstandardized
coefficients
Standardized
coefficients
t
B Standard error b
1 (Constant) 141.775 66.890 2.12
Height 391.364 40.071 0.446 9.76
2 (Constant) 169.242 63.859 2.65
Height 467.874 40.028 0.533 11.68
Weight 1.422 0.224 0.289 6.34
3 (Constant) 79.023 66.897 1.18
Height 419.834 41.220 0.479 10.18
Weight 1.031 0.242 0.210 4.25
Age 1.021 0.263 0.185 3.87
6MWD Z 6-minute walk distance.were major determinants of 6MWD. Age was a better pre-
dictor between the two with standardized coefficient of
0.288 (p Z 0.001), followed by height with standardized
coefficient of 0.158 (p Z 0.028) as shown in Table 4. The
collinearity/tolerance of excluding weight was 0.589
(p Z 0.700) and tolerance of excluding BMI was 0.902
(p Z 0.171). Weight and BMI did not have significant
contribution to 6MWD in Nigerian male participants.
Table 5 shows stepwise regression analysis of the pre-
dictors of 6MWD in female participants. Five models were
represented in the table; model 4 with the highest regres-
sion coefficient (0.542), highest R2 (0.294), and least SEE
(50.9) was considered the most appropriate to predictin combined participants.
Significance R R2 Adjusted R2 Standard error
of estimate
0 0.035 0.446 0.199 0.197 62.1
7 <0.000
0 0.008
9 0.001 0.525 0.275 0.271 59.1
4 0.001
1 0.238
5 <0.001 0.550 0.303 0.297 58.1
6 0.001
8 0.001
Table 4 Stepwise regression analysis of the predictors of 6MWD in male participants.
Model Unstandardized
coefficients
Standardized
coefficients
t Significance R R2 Adjusted R2 Standard error
of estimate
B Standard error b
1 (Constant) 609.106 14.890 40.906 <0.001 0.334 0.112 0.107 62.4
Age 1.850 0.383 0.334 4.834 <0.001
2 (Constant) 336.858 123.871 2.719 0.007 0.367 0.135 0.125 61.7
Age 1.595 0.396 0.288 4.031 0.001
Height 153.142 69.184 0.158 2.214 0.028
6MWD Z 6-minute walk distance.
696MWD in female participants and represented as Eq. (3).
Eq. (3) shows that age, height, weight, and BMI were de-
terminants of 6MWD. These four predictors gave an equa-
tion with the least SEE, as shown in Table 5. The strongest
predictor of 6MWD in female participants was age with
standardized coefficient of 0. 211 (pZ 0.003) followed by
BMI with b of 2.196 (p Z 0.008), then by weight with a
standardized coefficient of þ2.025 (p Z 0.018), which was
then followed by height with standardized coefficient of
0.392 (p Z 0.158) with SEE of 50.9 (Table 5). The 6MWD
had negative correlation with height, age, BMI, and had
positive correlation with weight of female participants.
Stepwise multiple regression equations to predict
6MWD in a Nigerian population:
6MWDCombined[
h
419:834HeightðmÞ
i

h
1:021 AgeðyearsÞ
i

h
1:031WeightðkgÞ
i
 79:023
ðSEE[ 58:050; R[ 0:550Þ
ð1Þ
6MWDMale[
h
153:142HeightðmÞ
i

h
1:595 AgeðyearsÞ
i
þ 336:585 ðSEE[61:713; R[ 0:367Þ
ð2Þ
6MWDFemale[1253:862
h
406:447HeightðmÞ
i

h
1:010 AgeðyearsÞ
i

h
7:890WeightðkgÞ
i
 ð23:551  BMIÞ ðSEE[ 50:856; R[0:542Þ
ð3Þ
Comparison of the measured 6MWD with estimated 6MWD
from foreign prediction equations is shown in Table 6. The
table shows that the mean 6MWD covered by Nigerians was
517.6  72 m (male, 548.9  67.9 m vs. female,
482.5  59.9 m). The 6MWD measured in Nigerian partici-
pants (517.6  72.0 m) was statistically lower than pre-
dicted values from Americans (647.3  91.0.4 m;
p < 0.001), Brazilians (616.6  23.1 m, p < 0.001), Tuni-
sians (830.3  84.1 m, p < 0.001), and significantly higher
than Arabian population ( 472.3  21.1, p < 0.001).
When the comparison was made based on the sex, male
participants covered significantly longer distance than their
female counterparts (Table 2).Discussion
The aims of this study were to determine 6MWD, establish
prediction equations for 6MWD in apparently healthy
Nigerians, evaluate effects of sex on distance covered, and
compare measured 6MWD with predicted 6MWD from
existing reference equations derived from other pop-
ulations. It is noteworthy that this is the first study to
establish prediction equations for 6MWD using 6MWT in
apparently healthy Nigerians. The sample size in this study
was comparable to those used in the previous studies
[22,25e28]. The mean 6MWD in apparently healthy Niger-
ians between 21 and 67 years (male, 21e67 years; female,
25e57 years) was 517.6  72.2 m (male, 548.9  67.9 m;
female, 482.5  59.9 m). This age range is a representative
of individuals undergoing cardiovascular/cardiopulmonary
rehabilitation in Nigeria [11]. Male participants were taller
than their female counterparts while the female partici-
pants had higher body mass index, though the weights were
comparable (Table 1). The higher BMI in female participants
observed may be attributed to the shorter height observed
in the female participants. This study shows that appar-
ently healthy Nigerian male covered significantly longer
distance during 6MWT than their female counterparts. The
age range of participants involved in this study is consistent
with the study of Tsang [24] (21e67 years vs. 21e70 years).
He equally reported that male participants covered longer
distance in 6 minutes than their female counterparts in a
Chinese population with mean difference of 62.0 m
(635.0 m vs. 573.0 m), whereas in our study, the mean
difference between male and female participants was
66.4 m (548.9 m vs. 482.5 m). Chinese participants in
Tsang’s study covered longer distance than Nigerian par-
ticipants; this difference may be attributed to the higher
BMI reported in our study.
The result of this study showed negative correlation
between the 6MWD and age, weight, and BMI and positive
correlation with height. These results are consistent with
the previous studies [25e28]. Most studies emphasized the
correlations between the 6MWD and age, height, weight,
and BMI in their various study populations because they are
very easy to obtain and cost effective. The data can be
easily obtained without depending on sophisticated equip-
ment. The negative correlation of age with 6MWD (Table 2)
agreed with the results of the previous studies [31,32].
They reported reductions in 6MWD with increasing age in
the adults and elderly population studied. The shorter
distance walked with advanced age can be attributed to
Table 5 Stepwise regression analysis of the predictors of 6MWD in female participants.
Model Unstandardized
coefficients
Standardized
coefficients
t Significance R R2 Adjusted R2 Standard error
of estimate
B Standard error b
1 (Constant) 552.835 11.542 47.896 <0.001 0.419 0.176 0.172 54.5
Age 1.913 0.296 0.419 6.467 <0.001
2 (Constant) 141.963 108.763 1.305 0.193
Age 1.751 0.289 0.384 6.050 <0.001 0.482 0.233 0.225 52.7
Height 249.765 65.766 0.241 3.798 <0.001
3 (Constant) 171.013 106.500 1.606 0.110
Age 1.122 0.341 0.246 3.287 0.001
Body mass index 2.607 0.794 0.243 3.284 0.001 0.523 0.273 0.262 51.5
4a (Constant) 1253.862 465.812 2.692 0.008
Age 1.010 0.340 0.221 2.967 0.003
Height 406.447 286.726 0.392 1.418 0.158 0.542 0.294 0.279 50.9
Body mass index 23.551 8.811 2.196 2.673 0.008
Weight 7.890 3.306 2.025 2.386 0.018
5 (Constant) 594.036 17.861 33.259 <0.001
Age 1.059 0.340 0.232 3.118 0.002
Body mass index 11.431 2.138 1.066 5.346 <0.001 0.535 0.287 0.275 51.0
Weight 3.319 0.734 0.852 4.522 <0.001
6MWD Z 6-minute walk distance.
a Model chosen to establish the prediction equation for female participants.
70 O.A. Ajiboye et al.decreases in muscle mass and strength and the reduced
maximum oxygen consumption, inherent to the ageing
process [31,32]. Conversely, Priesnitz et al [33] and Ben
Saad et al [34] reported increases in 6MWD with increasing
age in children and adolescents, respectively. They asso-
ciated their results with higher degree of maturation among
adolescents when compared with children.Table 6 Comparison of measured distance in Nigerian participan
Participants 6MWD in this
study, mean  SD
6MWD (m) pre
from foreign e
mean  SD
Combined participants (m)
n Z 422
517.6  72.0
(364e741 m)
647.3  91.0a
648.2  90.4b
616.6  23.1c
830.4  84.2d
472.3  21.1e
Male participants
n Z 224
548.9  67.9
(403e741 m)
658.4  82.2a
655.8  79.5b
617.1  23.1c
844.1  75.5d
483.3  18.8e
Female participants
n Z 198
482.5  59.9
(364e608 m)
582.4  91.5a
641.0  99.4b
554.6  24.3c
625.5  84.0d
459.6  15.7e
*p < 0.001.
a,b Enright and Sherrill (1998) [25].
c Iwama et al (2009) [26].
d Ben Saad et al (2009) [27].
e Alameri et al (2009) [28].The significant positive correlation between height and
the distance walked during the 6MWT as observed in the
participants may be attributed to the longer length of steps
in taller individuals. The length of the step is one of the
main determinants in gait velocity [35]. The correlation
observed between the 6MWD and height in this study was
consistent with previous studies [26e28,36]. Only the studyts with predicted distance from foreign regression equations.
dicted
quations,
6MWD mean difference (m) t value p
129.7  88.9 29.9 <0.001*
130.6  90.1 29.9 <0.001*
99.0  67.0 30.3 <0.001*
312.8  82.6 77.6 <0.001*
45.3  62.7 6.6 <0.001*
109.5  83.8 18.5 <0.001*
106.9  85.4 16.4 <0.001*
68.2  62.1 55.6 <0.001*
295.2  79.1 8.2 <0.001*
65.6  61.6 1.6 0.106
99.9  82.3 15.5 <0.001*
158.5  89.7 24.9 <0.001*
72.1  54.4 19.7 <0.001*
143.0  81.4 21.4 <0.001*
23.3  57.8 1.0 0.118
71by Enright and Sherrill [25] showed no significant correla-
tion between the 6MWD and height.
The major determinants of 6MWD in male participants
were age and height (Table 4). No significant contribution
was observed between the 6MWD and weight and BMI of
male participants while these contributed significantly in
female participants (Table 5). This explains further why
weight and BMI were not selected as determinants of 6MWD
in male participants. In Nigerian adults’ population, prev-
alence of obesity among women and men in an urban
centre was reported to be 17.27% and 2.25%, respectively,
by Olatunbosun et al [37]. Their reports showed that
obesity is more prevalent among Nigerian females than
their male counterpart.
The major determinants of 6MWD in the overall analysis
are height with standardized coefficient of 0.479, p< 0.001,
weight with standardized coefficient of 0.210, pZ 0.001,
and age with standardized coefficient of 0.185, pZ 0.001
(RZ 0.550, SEEZ 58.1). In the male participants, age was
found to be a better predictor of 6MWD with standardized
coefficient of 0.228 (p Z 0.001) followed by height with
standardized coefficient of 0.158 (p Z 0.028), whereas in
the female participants, age was found to be the most sig-
nificant predictor of 6MWD with standardized coefficient of
0.221 (pZ 0.003) followed by BMI and weight. Height was
not found to be a significant predictor of 6MWD in female
participants. The results of this study corroborate the find-
ings of previous researchers on the necessity for sex-specific
prediction equations to be established.
Among Nigerian adults, male participants walked an
average of 66.4 m more than their female counterparts.
This result is consistent with previous studies [22,24e28].
The difference in the distance covered during the 6MWT
between the male and female participants may be attrib-
uted to higher muscular strength and mass seen in men
compared with women. More so, higher height in male
participants observed might contribute to this difference.
By contrast, some studies among the adolescents [28,33]
did not show that participant sex affected 6MWD. They
attributed their results to similar musculoskeletal behav-
iour between males and females before adolescence [33].
The 6MWD measured in this study was significantly less
than the predicted 6MWD from regression equations
derived in American and Asian populations. This result is
consistent with previous studies [22,38,39]. The implica-
tions of this for patients with chronic obstructive pulmo-
nary diseases or CHF and other chronic diseases may be
considerable, and include an overestimation or underesti-
mation of the level of a patient’s ability or disability as well
as the potential for setting unrealistic outcomes from in-
terventions aimed at improving the walking capacity of
these patients. The prediction equations for 6MWD derived
from this study should therefore be used in the Nigerian
population.Conclusion
This study shows that regression equations derived for
other populations may not be appropriate to predict 6MWD
in Nigerian individuals. The prediction equations presented
in this study should be used for estimating 6MWD in Nigeria.Conflicts of interest
All contributing authors declare no conflicts of interest.References
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